BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37221386)

  • 1. Surgical and Oncological Outcomes of Wedge Resection Versus Segment 4b + 5 Resection for T2 and T3 Gallbladder Cancer: a Meta-Analysis.
    Matsui S; Tanioka T; Nakajima K; Saito T; Kato S; Tomii C; Hasegawa F; Muramatsu S; Kaito A; Ito K
    J Gastrointest Surg; 2023 Sep; 27(9):1954-1962. PubMed ID: 37221386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wedge resection versus segment IVb and V resection of the liver for T2 gallbladder cancer: a systematic review and meta-analysis.
    Chen Z; Yu J; Cao J; Lin C; Hu J; Zhang B; Shen J; Feng X; Topatana W; Chen M; Fang H
    Front Oncol; 2023; 13():1186378. PubMed ID: 37469411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.
    Chen M; Cao J; Xiang Y; Ma X; Bai Y; Lai Q; Tong C; Ma Z; Topatana W; Hu J; Li S; Juengpanich S; Yu H; Cai X
    Surgery; 2021 Jun; 169(6):1304-1311. PubMed ID: 33551070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.
    Fuks D; Regimbeau JM; Le Treut YP; Bachellier P; Raventos A; Pruvot FR; Chiche L; Farges O
    World J Surg; 2011 Aug; 35(8):1887-97. PubMed ID: 21547420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
    Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
    Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.
    Cavallaro A; Piccolo G; Panebianco V; Lo Menzo E; Berretta M; Zanghì A; Di Vita M; Cappellani A
    World J Gastroenterol; 2012 Aug; 18(30):4019-27. PubMed ID: 22912553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic segment 4b+5 liver resection for stage T3 gallbladder cancer.
    Huang L; Zhang C; Tian Y; Liao C; Yan M; Qiu F; Zhou S; Lai Z; Wang Y; Lin Y; Chen S
    Surg Endosc; 2022 Dec; 36(12):8893-8907. PubMed ID: 35906460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer.
    Chong JU; Lee WJ
    Yonsei Med J; 2019 Dec; 60(12):1138-1145. PubMed ID: 31769244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of wedge resection of gallbladder bed and lymphadenectomy on adequate oncologic clearance for gallbladder cancer.
    Tewari M; Kumar S; Shukla S; Shukla HS
    Indian J Cancer; 2016; 53(4):552-557. PubMed ID: 28485349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.
    Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY
    World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study.
    Tharmalingam S; Flemming J; Richardson H; Hurlbut D; Cleary S; Nanji S
    Can J Surg; 2022; 65(1):E16-E24. PubMed ID: 35017185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving margin negative resection-doing less is justified: oncological outcomes of wedge excision of liver in gallbladder cancer (GBC) surgery.
    Patkar S; Patil V; Acharya MR; Kurunkar S; Goel M
    Chin Clin Oncol; 2019 Aug; 8(4):38. PubMed ID: 31431034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Oncologic Outcomes for T2 Gallbladder Cancer According to the Type of Surgery Performed and the Optimal Timing for Sequential Extended Cholecystectomy.
    Oh MY; Kim H; Sohn HJ; Lee S; Lee M; Kim HS; Han Y; Kwon W; Jang JY
    J Gastrointest Surg; 2022 Aug; 26(8):1705-1712. PubMed ID: 35641810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity Score Analysis of Outcomes Following Laparoscopic or Open Radical Resection for Gallbladder Cancer in T2 and T3 Stages.
    Dou C; Zhang C; Zhang C; Liu J
    J Gastrointest Surg; 2022 Jul; 26(7):1416-1424. PubMed ID: 35296956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406).
    Higuchi R; Ono H; Matsuyama R; Takemura Y; Kobayashi S; Otsubo T; Abe Y; Endo I; Tanabe M; Yamamoto M;
    BMC Gastroenterol; 2022 Mar; 22(1):152. PubMed ID: 35346072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic safety of robotic extended cholecystectomy for gallbladder cancer.
    Cho YJ; Yun WG; Jung HS; Lee M; Han Y; Kwon W; Jang JY
    Surg Endosc; 2023 Dec; 37(12):9089-9097. PubMed ID: 37798528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?
    Choi SB; Han HJ; Kim WB; Song TJ; Suh SO; Choi SY
    Langenbecks Arch Surg; 2013 Dec; 398(8):1137-44. PubMed ID: 24057276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Outcomes After Bile Spillage in Incidental Gallbladder Cancers: A Population-based Study.
    Horkoff MJ; Ahmed Z; Xu Y; Sutherland FR; Dixon E; Ball CG; Bathe OF
    Ann Surg; 2021 Jan; 273(1):139-144. PubMed ID: 30998534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.